202 related articles for article (PubMed ID: 28797737)
1. NKT cells are important mediators of hepatic ischemia-reperfusion injury.
Richards JA; Wigmore SJ; Anderton SM; Howie SEM
Transpl Immunol; 2017 Dec; 45():15-21. PubMed ID: 28797737
[TBL] [Abstract][Full Text] [Related]
2. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
Arrenberg P; Maricic I; Kumar V
Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
[TBL] [Abstract][Full Text] [Related]
3. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
Zhu H; Zhang Q; Chen G
Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
[TBL] [Abstract][Full Text] [Related]
4. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.
Kuboki S; Sakai N; Tschöp J; Edwards MJ; Lentsch AB; Caldwell CC
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1054-9. PubMed ID: 19264952
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.
Lappas CM; Day YJ; Marshall MA; Engelhard VH; Linden J
J Exp Med; 2006 Nov; 203(12):2639-48. PubMed ID: 17088433
[TBL] [Abstract][Full Text] [Related]
6. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor.
Cao Z; Yuan Y; Jeyabalan G; Du Q; Tsung A; Geller DA; Billiar TR
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G249-58. PubMed ID: 19556359
[TBL] [Abstract][Full Text] [Related]
7. Ischemia-reperfusion Injury in Allogeneic Liver Transplantation: A Role of CD4 T Cells in Early Allograft Injury.
Kageyama S; Kadono K; Hirao H; Nakamura K; Ito T; Gjertson DW; Sosa RA; Reed EF; Kaldas FM; Busuttil RW; Kupiec-Weglinski JW; Zhai Y
Transplantation; 2021 Sep; 105(9):1989-1997. PubMed ID: 33065722
[TBL] [Abstract][Full Text] [Related]
8. RORγt(+) IL-22-producing NKp46(+) cells protect from hepatic ischemia reperfusion injury in mice.
Eggenhofer E; Sabet-Rashedi M; Lantow M; Renner P; Rovira J; Koehl GE; Schlitt HJ; Geissler EK; Kroemer A
J Hepatol; 2016 Jan; 64(1):128-34. PubMed ID: 26341825
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-Inducible Factor-2α Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury.
Zhang J; Han C; Dai H; Hou J; Dong Y; Cui X; Xu L; Zhang M; Xia Q
J Am Soc Nephrol; 2016 Jan; 27(1):92-106. PubMed ID: 25956511
[TBL] [Abstract][Full Text] [Related]
10. IL-17A-producing NK cells were implicated in liver injury induced by ischemia and reperfusion.
Feng M; Li G; Qian X; Fan Y; Huang X; Zhang F; Lu L
Int Immunopharmacol; 2012 Jun; 13(2):135-40. PubMed ID: 22465963
[TBL] [Abstract][Full Text] [Related]
11. Normal mouse kidneys contain activated and CD3+CD4- CD8- double-negative T lymphocytes with a distinct TCR repertoire.
Ascon DB; Ascon M; Satpute S; Lopez-Briones S; Racusen L; Colvin RB; Soloski MJ; Rabb H
J Leukoc Biol; 2008 Dec; 84(6):1400-9. PubMed ID: 18765477
[TBL] [Abstract][Full Text] [Related]
12. NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury.
Li L; Huang L; Sung SS; Lobo PI; Brown MG; Gregg RK; Engelhard VH; Okusa MD
J Immunol; 2007 May; 178(9):5899-911. PubMed ID: 17442974
[TBL] [Abstract][Full Text] [Related]
13. Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.
Liu Y; Ji H; Zhang Y; Shen X; Gao F; He X; Li GA; Busuttil RW; Kuchroo VK; Kupiec-Weglinski JW
J Hepatol; 2015 Mar; 62(3):563-72. PubMed ID: 25450716
[TBL] [Abstract][Full Text] [Related]
14. Oral N-acetylcysteine decreases IFN-γ production and ameliorates ischemia-reperfusion injury in steatotic livers.
Liggett JR; Kang J; Ranjit S; Rodriguez O; Loh K; Patil D; Cui Y; Duttargi A; Nguyen S; He B; Lee Y; Oza K; Frank BS; Kwon D; Li HH; Kallakury B; Libby A; Levi M; Robson SC; Fishbein TM; Cui W; Albanese C; Khan K; Kroemer A
Front Immunol; 2022; 13():898799. PubMed ID: 36148239
[TBL] [Abstract][Full Text] [Related]
15. Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells.
Pommey S; Lu B; McRae J; Stagg J; Hill P; Salvaris E; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM
Hepatology; 2013 Apr; 57(4):1597-606. PubMed ID: 22829222
[TBL] [Abstract][Full Text] [Related]
16. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver.
Zwacka RM; Zhang Y; Halldorson J; Schlossberg H; Dudus L; Engelhardt JF
J Clin Invest; 1997 Jul; 100(2):279-89. PubMed ID: 9218504
[TBL] [Abstract][Full Text] [Related]
17. Sulfatide-reactive natural killer T cells abrogate ischemia-reperfusion injury.
Yang SH; Lee JP; Jang HR; Cha RH; Han SS; Jeon US; Kim DK; Song J; Lee DS; Kim YS
J Am Soc Nephrol; 2011 Jul; 22(7):1305-14. PubMed ID: 21617126
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of T cell depletion in murine renal ischemia-reperfusion injury.
Yokota N; Daniels F; Crosson J; Rabb H
Transplantation; 2002 Sep; 74(6):759-63. PubMed ID: 12364852
[TBL] [Abstract][Full Text] [Related]
19. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury.
Shen X; Wang Y; Gao F; Ren F; Busuttil RW; Kupiec-Weglinski JW; Zhai Y
Hepatology; 2009 Nov; 50(5):1537-46. PubMed ID: 19670423
[TBL] [Abstract][Full Text] [Related]
20. Loss of L-selectin-guided CD8
Kolachala VL; Palle S; Shen M; Feng A; Shayakhmetov D; Gupta NA
Hepatology; 2017 Oct; 66(4):1258-1274. PubMed ID: 28543181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
